I skjæringspunktet mellom lindring og helbredelse – utredning og behandling av Ikke-småcellet lungecancer stadium III.
Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.
Br J Cancer 2013 Sep 17;109(6):1467-75. Epub 2013 aug 20
PMID: 23963145 - Inngår i doktorgradsavhandlingen
Concurrent palliative chemoradiation leads to survival and quality of life benefits
British Journal of Cancer (2013) 109, 1467-1475
Poor prognosis patients wih inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy
J Thorac Oncol 2014;9: 825-833